Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Melanoma -

Melanoma

Molecular Biology, Risk Factors & Treatment Options

Alexander C Jones (Herausgeber)

Buch | Hardcover
267 Seiten
2013
Nova Science Publishers Inc (Verlag)
978-1-62808-608-9 (ISBN)
CHF 349,95 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Melanoma accounts for only 4% of all skin cancer cases but most of skin cancer-related death. The rising incidence of melanoma makes this tumour an important public health problem. In this book, the authors present current research in the study of the molecular biology, risk factors and treatment options for melanoma. Topics include the role of P13K/AKT and Wnt/ -Catenin pathways in melanoma's progression to metastatic disease; cutaneous melanoma; molecular determinants of melanoma vasculogenic mimicry; new aspects of the molecular biology of melanoma metastasis; the surgical extent of regional lymph node dissection for cutaneous melanoma and its novel techniques and modifications; the epidemiology of melanoma in young individuals; cardiac involvement in malignant melanoma; poor Karnofsky performance status and high serum lactate dehydrogenase level identifies patients with brain metastases from malignant melanoma who do not benefit from palliative whole brain radiotherapy; interferon-beta therapy; and boron neutron capture therapy.

Preface; Melanoma Progression to Metastatic Disease: The Role of the PI3K/AKT & Wnt/ -Catenin Pathways; Cutaneous Melanoma: Molecular Biology, Risk Factors & Treatment Options; Molecular Determinants of Melanoma Vasculogenic Mimicry; New Aspects of the Molecular Biology of Melanoma Metastasis; The Surgical Extent of Regional Lymph Node Dissection for Cutaneous Melanoma & its Novel Techniques & Modifications; Cutaneous Melanoma: Molecular Mechanisms & Current Therapeutic Approaches; Epidemiology of Melanoma in Young Individuals: A Systematic Review; Cardiac Involvement in Malignant Melanoma; Poor Karnofsky Performance Status & High Serum Lactate Dehydrogenase Level (KPS/LDH Index) Identifies Patients with Brain Metastases from Malignant Melanoma who do not Benefit from Palliative Whole Brain Radiotherapy; Short Communication: Interferon-Beta Therapy for Melanoma: A Review of the Literature; Molecular Targeted Therapy & Drug Resistance; Boron Neutron Capture Therapy for Melanoma Treatment; Index.

Verlagsort New York
Sprache englisch
Maße 180 x 260 mm
Gewicht 626 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-62808-608-4 / 1628086084
ISBN-13 978-1-62808-608-9 / 9781628086089
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 49,95